Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 809 of 1,261

  1. US 8754044

    Neuroprotection by hepatic cells and hepatocyte secretory factors

    Northwestern University · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  2. US 8754034

    Structure-based design of peptide inhibitors of amyloid fibrillation

    The Regents of the University of California · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  3. US 8754225

    Process for preparing a biphenyl-2-ylcarbamic acid

    Theravance, Inc. · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  4. US 8753660

    Activating extraction of demineralized bone matrix

    The Regents of the University of California · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  5. US 8754051

    Peptide modulators of the δPKC interaction with the d subunit of F1Fo ATP synthase/ATPase and uses thereof

    Georgia Regents Research Institute, Inc. · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  6. US 8754201

    Therapeutic compositions

    Alnylam Pharmaceuticals, Inc. · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  7. US 8754108

    Freeze-dried pantoprazole preparation and pantoprazole injection

    TAKEDA GMBH · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  8. US 8754223

    Crystalline form of a biphenyl compound

    Theravance, Inc. · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  9. US 8754222

    Process for preparing modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  10. US 8753682

    Dual release oral tablet compositions of dexlansoprazole

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  11. US 8754564

    Hydrogel implants with varying degrees of crosslinking

    Covidien LP · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  12. US 8754218

    Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives

    TAKEDA GMBH · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  13. US 8754224

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  14. US 8753646

    IPV-DPT vaccine

    Takeda Pharmaceutical Company Limited · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  15. US 8754233

    Pyrazolylbenzothiazole derivatives and their use as therapeutic agents

    Dermira (Canada), Inc. · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  16. US 8754080

    Pyrimidine substituted purine compounds as kinase (S) inhibitors

    VERASTEM, INC. · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  17. US 8754046

    MHC class II restricted T cell epitopes from the cancer anitgen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  18. US 8754030

    Defensin-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  19. US 8753649

    Polysaccharide-protein conjugate vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

  20. US 8747823

    Compositions and methods for treating a keratin based substrate

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  21. US 8748114

    ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  22. US 8747919

    Pharmaceutical composition and method of preparing same

    SAISEI MIRAI CLINIC · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  23. US 8747883

    Medical item for long term drug release

    Princeton Trade & Technology, Inc. · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

  24. US 8747872

    Nanoemulsion therapeutic compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.